Advertisement
Advertisement

NSPR

NSPR logo

InspireMD, Inc.

0.77
USD
Sponsored
-0.05
-6.24%
Jun 09, 16:00 UTC -4
Closed
exchange

After-Market

0.80

+0.03
+4.26%

InspireMD, Inc. Profile

About

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel.

Info & Links

CEO

Marvin Slosman

Headquarters

6303 WATERFORD DISTRICT DRIVE, SUITE 215
MIAMI, FL 33126, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.inspiremd.com

Auditor

Kesselman & Kesselman

Share holders

329

Employees

127

InspireMD, Inc. Statistics

Valuation Measures

Market Capitalization2

37.38M

Enterprise Value

26.02M

Enterprise Value/EBITDA(ttm)

-0.50

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

6.98

Price to Book(mrq)

1.03

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

27.10%

Operating Margin(ttm)

-543.33%

Profit Margin(ttm)

-586.78%

Return on Equity(ttm)

-116.22%

Return on Invested Capital(ttm)

-145.49%

Return on Assets(ttm)

-88.75%

Income Statement

Revenue(ttm)

10.85M

Revenue Per Share(ttm)

0.23

Gross Profit(ttm)

3.04M

EBITDA(ttm)3

-51.61M

Net Income Available to Common(ttm)

-51.31M

Diluted EPS(ttm)

-0.79

Share Statistics

Beta (5Y Monthly)

0.95

52-Week Change

-69.38%

S&P 500 52-Week Change

22.99%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

46.84M

Dividend Yield

0.00%

Float4

30.86M

% Held by Insiders

34.06%

% Held by Institutions

44.78%

Balance Sheet

Total Cash(mrq)

41.57M

Total Cash Per Share(mrq)

0.89

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.74%

Quick Ratio(mrq)

5.42%

Book Value Per Share(mrq)

1.27

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.55

Free Cash Flow(ytd)

-36.75M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement